These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 25648269)
1. Successful treatment of metastatic urothelial carcinoma arising in a transplanted renal allograft with paclitaxel, cisplatin, and gemcitabine combination therapy: a case report. Kojima Y; Takahi Y; Ichimaru N; Okumi M; Takahara S; Nonomura N BMC Res Notes; 2015 Feb; 8():25. PubMed ID: 25648269 [TBL] [Abstract][Full Text] [Related]
2. Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with advanced transitional cell carcinoma of the urothelium. Ecke TH; Bartel P; Koch S; Ruttloff J; Theissig F Oncol Rep; 2006 Dec; 16(6):1381-8. PubMed ID: 17089065 [TBL] [Abstract][Full Text] [Related]
3. Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987. Bellmunt J; von der Maase H; Mead GM; Skoneczna I; De Santis M; Daugaard G; Boehle A; Chevreau C; Paz-Ares L; Laufman LR; Winquist E; Raghavan D; Marreaud S; Collette S; Sylvester R; de Wit R J Clin Oncol; 2012 Apr; 30(10):1107-13. PubMed ID: 22370319 [TBL] [Abstract][Full Text] [Related]
4. Gemcitabine and paclitaxel chemotherapy for advanced urothelial carcinoma in patients who have received prior cisplatin-based chemotherapy. Kanai K; Kikuchi E; Ohigashi T; Miyajima A; Nakagawa K; Nakashima J; Oya M Int J Clin Oncol; 2008 Dec; 13(6):510-4. PubMed ID: 19093178 [TBL] [Abstract][Full Text] [Related]
5. Current and future perspectives in advanced bladder cancer: is there a new standard? von der Maase H Semin Oncol; 2002 Feb; 29(1 Suppl 3):3-14. PubMed ID: 11894002 [TBL] [Abstract][Full Text] [Related]
6. [Treatment and prognosis of 117 patients with advanced urothelial carcinoma of the bladder]. Song Y; Yang L; Zhou A; Chi Y; Wang J Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):212-6. PubMed ID: 24785283 [TBL] [Abstract][Full Text] [Related]
7. Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy. Ikeda M; Matsumoto K; Tabata K; Minamida S; Fujita T; Satoh T; Iwamura M; Baba S Jpn J Clin Oncol; 2011 Oct; 41(10):1214-20. PubMed ID: 21903707 [TBL] [Abstract][Full Text] [Related]
8. Palliative chemotherapy with gemcitabine, paclitaxel, and cisplatin as first-line treatment following gemcitabine monotherapy for patients with transitional cell carcinoma of the urothelium. Ecke TH; Gerullis H; Bartel P; Koch S; Ruttloff J Minerva Urol Nefrol; 2009 Mar; 61(1):1-8. PubMed ID: 19417721 [TBL] [Abstract][Full Text] [Related]
9. Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: a phase II study. Halim A; Abotouk N Asia Pac J Clin Oncol; 2013 Mar; 9(1):60-5. PubMed ID: 22897883 [TBL] [Abstract][Full Text] [Related]
10. Second Line Chemotherapy for Advanced and Metastatic Urothelial Carcinoma: Vinflunine and Beyond-A Comprehensive Review of the Current Literature. Oing C; Rink M; Oechsle K; Seidel C; von Amsberg G; Bokemeyer C J Urol; 2016 Feb; 195(2):254-63. PubMed ID: 26410730 [TBL] [Abstract][Full Text] [Related]
11. Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium. Milowsky MI; Nanus DM; Maluf FC; Mironov S; Shi W; Iasonos A; Riches J; Regazzi A; Bajorin DF J Clin Oncol; 2009 Sep; 27(25):4062-7. PubMed ID: 19636012 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy. Sternberg CN; Calabrò F; Pizzocaro G; Marini L; Schnetzer S; Sella A Cancer; 2001 Dec; 92(12):2993-8. PubMed ID: 11753976 [TBL] [Abstract][Full Text] [Related]
13. Gemcitabine Plus Cisplatin Split Izumi K; Iwamoto H; Yaegashi H; Shigehara K; Nohara T; Kadono Y; Mizokami A In Vivo; 2019; 33(1):167-172. PubMed ID: 30587618 [TBL] [Abstract][Full Text] [Related]
14. Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine. Bellmunt J; Albanell J; Paz-Ares L; Climent MA; González-Larriba JL; Carles J; de la Cruz JJ; Guillem V; Díaz-Rubio E; Cortés-Funes H; Baselga J; Cancer; 2002 Aug; 95(4):751-7. PubMed ID: 12209718 [TBL] [Abstract][Full Text] [Related]
15. [The efficacy and toxicity of gemcitabine and cisplatin chemotherapy in advanced/metastatic bladder urothelial carcinoma]. Gunlusoy B; Arslan M; Vardar E; Degirmenci T; Kara C; Ceylan Y; Kozacıoğlu Z Actas Urol Esp; 2012 Oct; 36(9):515-20. PubMed ID: 22819345 [TBL] [Abstract][Full Text] [Related]
16. Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen. Takahashi T; Higashi S; Nishiyama H; Segawa T; Nakamura E; Kinoshita H; Itoh N; Yamamoto S; Kamoto T; Habuchi T; Ogawa O Jpn J Clin Oncol; 2006 Feb; 36(2):104-8. PubMed ID: 16418182 [TBL] [Abstract][Full Text] [Related]
17. Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium. Lorusso V; Crucitta E; Silvestris N; Rosati G; Manzione L; De Lena M; Palmeri S; Gebbia V; Mancarella S; Sobrero A; Pezzella G; Comella P; Mangiameli A; Muci D; Oncol Rep; 2005 Feb; 13(2):283-7. PubMed ID: 15643512 [TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of paclitaxel and carboplatin as second-line chemotherapy for advanced urothelial carcinoma resistant to first-line therapy with gemcitabine and cisplatin. Terakawa T; Miyake H; Yokoyama N; Miyazaki A; Tanaka H; Inoue T; Fujisawa M Urol Int; 2014; 92(2):180-5. PubMed ID: 24246751 [TBL] [Abstract][Full Text] [Related]
19. Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network. Meluch AA; Greco FA; Burris HA; O'Rourke T; Ortega G; Steis RG; Morrissey LH; Johnson V; Hainsworth JD J Clin Oncol; 2001 Jun; 19(12):3018-24. PubMed ID: 11408496 [TBL] [Abstract][Full Text] [Related]
20. Successful management of metastatic urothelial carcinoma with gemcitabine and Paclitaxel chemotherapy in a hemodialysis patient. Ide H; Satou A; Hoshino K; Yasumizu Y; Uchida Y; Tasaka Y; Masuda T Urol Int; 2011; 87(2):245-7. PubMed ID: 21709400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]